Diagnostic preparations for medical purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic biomarkers for in vitro testing for medical use; Medical diagnostic reagents for the analysis of body fluids; Reagents for use in the detection, diagnosis, prognosis and monitoring of liver diseases, hepatic fibrosis, liver failure conditions and metabolic dysfunction-associated steatohepatitis (MASH); Reagents and diagnostic tests for screening and stratification of patients at risk of liver diseases and metabolic disorders; Medical diagnostic test in the form of algorithm-based blood test for identifying patients with liver diseases, hepatic fibrosis, liver failure conditions and metabolic dysfunction-associated steatohepatitis (MASH)

'agent':7 'algorithm':89 'algorithm-bas':88 'analysi':34 'associ':60,108 'base':90 'biomark':15,21 'blood':91 'bodi':36 'condit':55,103 'detect':43 'diagnosi':44 'diagnost':1,6,14,20,30,65,82 'diseas':50,77,98 'disord':80 'dysfunct':59,107 'dysfunction-associ':58,106 'failur':54,102 'fibrosi':52,100 'fluid':37 'form':86 'hepat':51,99 'identifi':94 'liver':49,53,76,97,101 'mash':62,110 'medic':4,12,18,27,29,81 'metabol':57,79,105 'monitor':47 'patient':72,95 'prepar':2,8 'prognosi':45 'purpos':5,13,19 'reagent':16,31,38,63 'risk':74 'screen':68 'steatohepat':61,109 'stratif':70 'substanc':10 'test':25,66,83,92 'use':28,40 'vitro':24

NASHNEXT

Owner

Goods & Services